A trial was run for the administration of Camicinal as an adjunct therapy with L-dopa and following was the outcome:
In total 19 patients received the inactive placebo and 37 received 50mg of the study medicine GSK 962040, also called Camicinal. Those patients who took Camicinal showed an improvement in “on” time where levodopa improved motor symptoms. Additionally, symptoms that can result from delayed gastric emptying such as constipation were slightly improved among some taking Camicinal – though a longer study is needed to confirm this. The study treatment was generally well tolerated throughout the study.
Please note that Camicinal is a motilin agonist for the treatment of gastroparesis.
has anyone tried the Fisher Wallace Stimulator? FDA-cleared since 1991 to treat depression/ anxiety/insomnia, but new research suggests more
Mucuna Pruriens in Parkinson's disease, dosages and effects, A double-blind, randomized, controlled, crossover human study (2017)
